GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Capital Expenditure

Acticor Biotech (XPAR:ALACT) Capital Expenditure : €-0.02 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Acticor Biotech's cash flow for capital expenditures for the six months ended in Jun. 2023 was €-0.02 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.02 Mil.

Acticor Biotech Capital Expenditure Historical Data

The historical data trend for Acticor Biotech's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Capital Expenditure Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Capital Expenditure
Get a 7-Day Free Trial -0.06 -0.02 -0.05 -0.01 -0.01

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only -0.01 -0.01 -0.01 - -0.02

Acticor Biotech Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acticor Biotech (XPAR:ALACT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Capital Expenditure
Comparable Companies
XPAR:ALCLS XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:ALVAL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
7V7:Germany
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Website
https://www.acticor-biotech.com
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines